Insider · CIK 0002071237
Lindsay Clinton Fitzgerald
Files at GEVO (Gevo, Inc.). First filing Jun 4, 2025, latest Mar 12, 2026.
Lindsay Clinton Fitzgerald files SEC Form 4 as officer at GEVO (Gevo, Inc.). Since Jun 4, 2025, Lindsay Clinton Fitzgerald has reported 0 open-market buys worth $0 and 4 open-market sells worth $77k, the latest filed on Mar 12, 2026.
A track record needs three past buys with six months of prices behind them; Lindsay Clinton Fitzgerald has 0, so none is measured yet.
The newest scored trade: sold $50k of GEVO on Mar 12, 2026, filed Mar 12, 2026, scored 17 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 1 sell worth $50k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
GEVO: Gevo, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 17Weak | Gevo, Inc. | $50k 20,000 shares | -9% | +138% from low-8% from high | |
| 10Weak | Gevo, Inc. | $9,990 8,118 shares | -3% | +66% from low-63% from high | |
| 10Weak | Gevo, Inc. | $6,496 5,185 shares | -2% | +65% from low-63% from high | |
| 10Weak | Gevo, Inc. | $10k 8,987 shares | -5% | +61% from low-64% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Aug 5, 2025 | GEVO Gevo, Inc. | 8,118 0.00% of outstanding | $9,990 | Aug 5, 2025 | $17k |
| Aug 1, 2025 | GEVO Gevo, Inc. | 5,185 0.00% of outstanding | $6,496 | Aug 1, 2025 | $10k |
| Jun 3, 2025 | GEVO Gevo, Inc. | 8,987 0.00% of outstanding | $10k | Jun 3, 2025 | none |
Transactions
Every row this insider has filed, 8 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 20, 2026 | GEVO Gevo, Inc. | AGrant or award Common Stock | +59,451 | $0.00 | $0 | 271,650 | May 22, 2026 |
| May 20, 2026 | GEVO Gevo, Inc. | AGrant or award Stock Optionderivative | +68,690 | $0.00 | $0 | 68,690 | May 22, 2026 |
| Mar 12, 2026 | GEVO Gevo, Inc. | SOpen-market sale Common Stock10b5-1 | -20,000 | $2.51 | $50k | 212,199 | Mar 12, 2026 |
| Aug 5, 2025 | GEVO Gevo, Inc. | SOpen-market sale Common Stock10b5-1 | -8,118 | $1.23 | $9,990 | 232,199 | Aug 6, 2025 |
| Aug 1, 2025 | GEVO Gevo, Inc. | SOpen-market sale Common Stock10b5-1 | -5,185 | $1.25 | $6,496 | 240,317 | Aug 4, 2025 |
| Jun 9, 2025 | GEVO Gevo, Inc. | AGrant or award Common Stock | +84,033 | $0.00 | $0 | 245,502 | Jun 11, 2025 |
| Jun 9, 2025 | GEVO Gevo, Inc. | AGrant or award Stock Optionderivative | +250,647 | $0.00 | $0 | 250,647 | Jun 11, 2025 |
| Jun 3, 2025 | GEVO Gevo, Inc. | SOpen-market sale Common Stock10b5-1 | -8,987 | $1.16 | $10k | 161,469 | Jun 4, 2025 |
Questions about Lindsay Clinton Fitzgerald
Answered from the filings on this page, as of the latest one.
Is Lindsay Clinton Fitzgerald buying or selling?
In the last 12 months Lindsay Clinton Fitzgerald reported 0 open-market buys worth $0 and 1 open-market sell worth $50k on SEC Form 4; the latest was sold $50k of GEVO on Mar 12, 2026. Grants, option exercises and tax withholding are not counted.
How did Lindsay Clinton Fitzgerald's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Lindsay Clinton Fitzgerald has 0.
Where does Lindsay Clinton Fitzgerald file Form 4?
Lindsay Clinton Fitzgerald has filed Form 4 at GEVO (Gevo, Inc.) as Chief Advocacy Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.